Whole-exome sequencing (WES) has been instrumental in the discovery of novel genes and mechanisms causing Mendelian diseases. While this technology is now being successfully applied in a number of clinics, particularly to diagnose patients with rare diseases, it also raises a number of ethical, legal and social issues. In order to identify what challenges were directly foreseen by technology users, we performed a systematic review of the literature. In this paper, we focus on recent publications related to the use of WES in the pediatric context and analyze the most prominent challenges raised by technology users. This is particularly relevant considering that a) most patients currently undergoing testing using WES to identify the genetic b...
Recent advances in next-generation sequencing technologies have brought a paradigm shift in how medi...
abstract: The Dorrance Center for Rare Childhood Disorders is a unique research division at TGen (Th...
<p>Whole-exome sequencing (WES) represents a significant breakthrough in the field of human genetics...
Whole-exome sequencing (WES) has been instrumental in the discovery of novel genes and mechanisms ca...
International audienceBACKGROUND:Whole-exome sequencing (WES) consists in the capture, sequencing an...
International audienceBACKGROUND:Whole-exome sequencing (WES) consists in the capture, sequencing an...
International audienceBACKGROUND:Whole-exome sequencing (WES) consists in the capture, sequencing an...
International audienceBACKGROUND:Whole-exome sequencing (WES) consists in the capture, sequencing an...
Contains fulltext : 196384.pdf (publisher's version ) (Open Access)Currently, offe...
Background: In developed countries, global developmental disorders are encountered in approximately ...
Over the past several years whole exome sequencing (WES) by high-throughput sequencing of target-enr...
Over the past several years whole exome sequencing (WES) by high-throughput sequencing of target-enr...
Pediatric neurological disorders have a wide spectrum of clinical presentations and can be challengi...
About 80% of the roughly 7,000 known rare diseases are single gene disorders, about 85% of which are...
About 80% of the roughly 7,000 known rare diseases are single gene disorders, about 85% of which are...
Recent advances in next-generation sequencing technologies have brought a paradigm shift in how medi...
abstract: The Dorrance Center for Rare Childhood Disorders is a unique research division at TGen (Th...
<p>Whole-exome sequencing (WES) represents a significant breakthrough in the field of human genetics...
Whole-exome sequencing (WES) has been instrumental in the discovery of novel genes and mechanisms ca...
International audienceBACKGROUND:Whole-exome sequencing (WES) consists in the capture, sequencing an...
International audienceBACKGROUND:Whole-exome sequencing (WES) consists in the capture, sequencing an...
International audienceBACKGROUND:Whole-exome sequencing (WES) consists in the capture, sequencing an...
International audienceBACKGROUND:Whole-exome sequencing (WES) consists in the capture, sequencing an...
Contains fulltext : 196384.pdf (publisher's version ) (Open Access)Currently, offe...
Background: In developed countries, global developmental disorders are encountered in approximately ...
Over the past several years whole exome sequencing (WES) by high-throughput sequencing of target-enr...
Over the past several years whole exome sequencing (WES) by high-throughput sequencing of target-enr...
Pediatric neurological disorders have a wide spectrum of clinical presentations and can be challengi...
About 80% of the roughly 7,000 known rare diseases are single gene disorders, about 85% of which are...
About 80% of the roughly 7,000 known rare diseases are single gene disorders, about 85% of which are...
Recent advances in next-generation sequencing technologies have brought a paradigm shift in how medi...
abstract: The Dorrance Center for Rare Childhood Disorders is a unique research division at TGen (Th...
<p>Whole-exome sequencing (WES) represents a significant breakthrough in the field of human genetics...